Intraoperative imaging of renal cortical tumors and cysts

Patent metadata

Field	Value
Publication number	US-RE45916-E
Application number	US-201514732721-A
Country	US
Kind code	E1
Filing date	Jun 6, 2015
Priority date	Aug 10, 2006
Publication date	Mar 8, 2016
Grant date	Mar 8, 2016

Abstract

The invention provides methods for visualizing renal tumors and for staging cysts during an operation by use of a fluorescent dye.

First claim

What is claimed is:

1. A method of detecting the presence or absence of a tumor in an area of a kidney in a subject during a surgical operation, comprising:
a) intravenously administering to said subject indocyanine green (ICG) which fluoresces at a near infrared emission wavelength when said dye is contacted with a near infrared excitation wavelength;
b) illuminating said kidney during said operation with said near infrared excitation wavelength such that the ICG in said kidney fluoresces; and,
c) detecting the presence or absence of fluorescence of the ICG in said kidney during said operation, using a video camera with optical filtering to block ambient and laser light, wherein detecting absence of fluorescence in said area indicates the presence of a tumor in said area, and detecting the presence of fluorescence in said area indicates the absence of a tumor in said area.

2. A method of claim 1 , wherein there are a plurality of tumors in said kidney.

3. A method of claim 1 , wherein said dye is administered locally into the renal artery, the superior segmental artery, anterior superior segmental artery, anterior inferior segmental artery, inferior segmental artery, an arcuate artery, or an interlobular artery.

4. A method of claim 1 , wherein said tumor is visualized on an image display.

5. A method of claim 1 , wherein said exposing of said kidney to said illumination comprising said excitation wavelength is by a laproscopic instrument.

6. A method of claim 1 , wherein the subject is a human.

7. A method of claim 1 , wherein said dye is administered during said surgical operation.

8. A method of claim 1 , wherein said dye is administered within 1 hour before said surgical operation.

9. A method of claim 8 , wherein said dye is administered within about ½ hour before said surgical operation.

10. A method of claim 8 , wherein said dye is administered within about ½ hour before said surgical operation.

11. A method of visualizing a tumor in a kidney in a subject during a surgical operation, comprising:
a) intravenously administering to said subject indocyanine green (ICG) which fluoresces at a near infrared emission wavelength when said dye is contacted with a near infrared excitation wavelength;
b) illuminating said kidney during said operation with said near infrared excitation wavelength such that the ICG in said kidney fluoresces; and,
c) visualizing the presence or absence of fluorescence of the ICG in said kidney during said operation, using a video camera with optical filtering to block ambient and laser light, wherein visualizing an area of said kidney in which fluorescence is absent is a visualization of said tumor.

12. A method of claim 11 , wherein there are a plurality of tumors in said kidney.

13. A method of claim 11 , wherein said dye is administered locally into the renal artery, the superior segmental artery, anterior superior segmental artery, anterior inferior segmental artery, inferior segmental artery, an arcuate artery, or an interlobular artery.

14. A method of claim 11 , wherein said tumor is visualized on an image display.

15. A method of claim 11 , wherein said exposing of said kidney to said illumination comprising said excitation wavelength is by a laproscopic instrument.

16. A method of claim 11 , wherein the subject is a human.

17. A method of claim 11 , wherein said dye is administered during said surgical operation.

18. A method of claim 11 , wherein said dye is administered within 1 hour before said surgical operation.

19. A method of visualizing a tumor margin in tissue excised from a kidney during a surgical operation, comprising:
a) intravenously administering to said subject indocyanine green (ICG) which fluoresces at a near infrared emission wavelength when said dye is contacted with a near infrared excitation wavelength,
b) excising some or all of a tumor and surrounding tissue from said kidney during said operation,
c) illuminating said kidney during said operation with said near infrared excitation wavelength such that the ICG in said kidney fluoresces; and
d) visualizing the presence or absence of fluorescence of the ICG, using a video camera with optical filtering to block ambient and laser light, wherein visualizing fluorescence around said some or all of said tumor indicates the presence of a tumor margin, and an absence of said fluorescence around some or all of said tumor indicates the absence of a tumor margin.

20. A method of claim 19 , wherein there are a plurality of tumors in said kidney.

21. A method of claim 19 , wherein said dye is administered locally into the renal artery, the superior segmental artery, anterior superior segmental artery, anterior inferior segmental artery, inferior segmental artery, an arcuate artery, or an interlobular artery.

22. A method of claim 19 , wherein said tumor and any surrounding tissue is visualized on an image display.

23. A method of claim 19 , wherein the subject is a human.

24. A method of determining during a surgical operation whether a cyst in a kidney in a subject is benign or contains malignant cells, comprising:
a) intravenously administering to said subject a dye indocyanine green (ICG) which fluoresces at an a near infrared emission wavelength when said dye ICG is contacted with an a near infrared excitation wavelength;
b) illuminating said cyst during said operation with said near infrared excitation wavelength under conditions such that the ICG in said cyst fluoresces; and,
c) comparing the fluorescence of said dye the ICG in said cyst during said operation to the fluorescence of surrounding kidney tissue, using a video camera with optical filtering to block ambient and laser light, wherein bright fluorescence in said cyst compared to said surrounding kidney tissue indicates that the cyst is benign and low or no fluorescence in said cyst compared to said surrounding kidney tissue indicates that the cyst contains malignant cells.

25. A method of claim 24 , wherein said dye is administered locally into the renal artery, the superior segmental artery, anterior superior segmental artery, anterior inferior segmental artery, inferior segmental artery, an arcuate artery, or an interlobular artery.

26. A method of claim 24 , wherein said cyst is visualized on an image display.

27. A method of claim 24 , wherein said exposing of said cyst to said illumination comprising said excitation wavelength is by a laproscopic instrument.

Assignees

• Univ Rochester

Inventors

• Golijanin Dragan
• Wood Ronald
• Messing Edward M

Classifications

• A61B5/418

  lymph vessels, ducts or nodes · CPC title

• A61K49/0034 Primary

  Indocyanine green, i.e. ICG, cardiogreen · CPC title

• A61B5/0071

  by measuring fluorescence emission · CPC title

• A61B5/411

  Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance · CPC title

• A61B5/415

  the glands, e.g. tonsils, adenoids or thymus · CPC title